2023年

Sakae H, Futaba M, Yamaguchi T, Kaburagi M, Nakano M, Iwamuro H, Takasaki M, Iijima K, Kanouchi M, Sasanuma J, Watanabe K, Yasuhiro H, Yamano Y.
Effectiveness and safety of magnetic resonance-guided focused ultrasound thalamotomy in patients with essential tremor who have low skull density ratio: A study of 101 cases.
Journal of Neurosurgery, 2023 in press.🆕

Sakurai K, Isahaya K, Imai T, Yamano Y.
Impact of early introduction of biologics on internal medications for neuromyelitis optica spectrum disorder.
Clin Exp Neuroimmunol, 2023  in press.🆕
doi:10.1111/cen3.12760

Takao N, Yagishita N, Araya N, Aratani S, Yamauchi J, Takahashi K, Kunitomo Y, Sato T, Nakamori M, Kawai Y, Omae Y, Tokunaga K, Matsuda Fumihiko, Mitsuhashi S and Yamano Y.
A Large-Scale Whole-Genome Analysis of HTLV-1-Associated Myelopathy Identified Hereditary Spastic Paraplegias.
Neurology Genetics, 2023 in press.🆕

Kuramitsu M, Momose H, Uchida Y, Ishitsuka K, Kubota R, Tokunaga M, Utsunomiya A, Hashikura Y, Umekita K, Nosaka K, Koh Ki-Ryang , Nakamura H, Sagara Y, Sobata R, Satake Ma, Nagata K, Hasegawa Y, Sasaki D, Hasegawa H, Sato T, Yamano Y, Hiraga K, Tezuka K, Ikebe E, Matsuoka S, Okuma K, Watanabe T, Miura K, and Hamaguchi I.
Performance evaluation of ESPLINE HTLV-I/II, a newly developed rapid immunochromatographic antibody test, for different diagnostic situations.
Journal of Clinical Microbiology, 2023 in press.🆕

kaburagi M, Maki F, Hino S, Nakano M, Yamaguchi T, Takasaki M, Iwamuro H, Iijima K, Sasanuma J, Watanabe K, Hasegawa Y, Yamano Y.
Video Motion Analysis as a Quantitative Evaluation Tool for Essential Tremor during Magnetic Resonance-Guided Focused Ultrasound Thalamotomy.
Neurol Int, 15(4):1411-1422, 2023.🆕
doi.org/10.3390/neurolint15040091

Yoshie T, Ueda T, Hasegawa Y, Takeuchi M, Morimoto M, Tsuboi Y, Yamamoto R, Kaku S, Ayabe J, Akiyama T, Yamamoto D, Mori K, Kagami H, Ito H, Onodera H, Kaga Y, Ohtsubo H, Tatsuno Z, Usuki N, Takaishi S, Yamano Y; K-NET Registry Investigators.
Ischemic stroke patients with low DWI ASPECTS scores require puncture to recanalization within 30 min for large vessel occlusion.
J Neurol Sci, 454:120852, 2023.🆕
doi: 10.1016/j.jns.2023.120852.

Kawano N, Yamada K, Miyoshi H, Yoshida N, Ohshima K, Arakawa F, Nakashima K, Kameda T, Kogure Y, Ito Y, Yoshida S, Kuriyama T, Nakaike T, Tochigi T, Yamashita K, Toyofuku A, Manabe T, Doi A, Terasaka S, Marutsuka K, Ochiai H, Kikuchi I, Mori Y, Kataoka K, Yoshizumi T, Yamauchi J, Yamano Y, Shimoda K.
The development of adult T-cell leukemia/lymphoma in renal transplant recipients;Report of two cases with literature review.
Renal Replacement Therapy, 9:36, 2023.
doi.org/10.1186/s41100-023-00480-5

Abe M, Yaguchi H, Kudo A, Nagai A, Shirai S, Takahashi-Iwata I, Matsushima M, Nakamura N, Isahaya K, Yamano Y, Ashida S, Kasai T, Tanaka K, Watanabe M, Kondo T, Takahashi H, Hatakeyama S, Takekoshi A, Kimura A, Shimohara T, Yabe I.
Sez6l2 autoimmunity in a large cohort study.
Journal of neurology, neurosurgery, and psychiatry, 94(8):667-668, 2023.
doi.org/10.1136/jnnp-2022-330194

Watanabe M, Hatsuse H, Nagao K, Nakashima M, Uchimaru K, Otsu M, Miyazaki K, Horie R.
CD30 induces Reed-Sternberg cell-like morphology and chromosomal instability in classic Hodgkin lymphoma cell lines.
Cancer Sci, 114(8):3061-3469, 2023.
doi.org/10.1111/cas.15874

Koseki A, Araya N, Yamagishi M, Yamauchi J, Yagishita N, Takao N, Takahashi K, Kunitomo Y, Honma D, Araki K, Uchimaru K, Sato T, Yamano Y.
EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy.
Front Microbiol, 14:1175762, 2023.
doi.org/10.3389/fmicb.2023.1175762

Nakashima M and Uchimaru K.
CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma.
Int J Mol Sci, 24(10):8731, 2023.
doi.org/10.3390/ijms24108731

Nakashima M, Utsunomiya A, Watanabe T, Horie R, Uchimaru K.
The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma.
Cancer Sci, 114(4):1556-1568, 2023.
doi: 10.1111/cas.15706.

Sato T, Yamauchi J, Yagishita N, Araya N, Takao N, Ohta Y, Inoue E, Takahashi M, Yamagishi M, Suzuki Y, Uchimaru K, Matsumoto N, Hasegawa Y, Yamano Y.
Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathy.
Brain, 146(8):3181–3191, 2023.
doi: 10.1093/brain/awad139

Shiraishi M, Kamo T, Kumazawa R, Sasaki N, Isahaya K, Akiyama H, Furusawa Y, Onodera R, Fernandez J, Otuska M, Yamano Y.
A multicenter, prospective, observational study to assess the satisfaction of an integrated digital platform of online medical care and remote patient monitoring in Parkinson’s disease.
Neurology and Clinical Neuroscience, 11(3):109-177, 2023.
doi:10.1111/ncn3.12709.

Uchino K, Soga K, Shinohara K, Imai T, Motohashi I, Okuma H, Yamano Y.
Anti-myelin Oligodendrocyte Glycoprotein Antibody-positive Myelitis after Coronavirus Disease 2019.
Intern. Med, 62(10):1531-1535, 2023.
doi.org/10.2169/internalmedicine.0394-22

山野 嘉久.
特集にあたって.
神経治療学, 40(1):7, 2023年4月.
記事はこちら

八木下 尚子, 山野 嘉久.
Human T–cell leukemia virus type I関連脊髄症患者レジストリ「HAMねっと」.
神経治療学, 40(1):28-31, 2023年4月.
記事はこちら

鷹尾 直誠, 佐藤 知雄, 山内 淳司, 八木下 尚子, 堀部 恵梨佳, 山野 嘉久.
HTLV-1関連脊髄症（HAM）診療ガイドライン2019」の活用実態および内容の評価に関する全国アンケート調査.
臨床神経学, 63:433-440, 2023.
記事はこちら

星野 俊，伊藤 葵，清水 高弘，秋山 久尚，山野 嘉久.
延髄梗塞を合併した帯状疱疹性脊髄炎の 1 例.
BRAIN and NERVE, 75(3):269-273, 2023.

鷹尾 直誠, 山野 嘉久.
HTLV-1関連脊髄症（HAM）.
CLINICAL NEUROSCIENCE, 41(1):122-125, 2023年1月.